HSBC Holdings
AZN icon

HSBC Holdings’s AstraZeneca AZN Stock Holding History

HSBC Holdings’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-60,000
Closed -$4.21M – 2538
2018
Q2 		$4.21M Buy
+60,000
New +$4.32M 0.01% 1195

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

HSBC Holdings's AZN Position: Q1 2026 in Review

HSBC Holdings reduced its AstraZeneca (AZN) stake by 76% in Q1 2026, selling an estimated $3.92M and leaving 6,297 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1757.

HSBC Holdings first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. The position peaked at $494M in Q4 2021. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • HSBC Holdings held 6,297 shares of AstraZeneca worth $1.23M as of Q1 2026.
  • HSBC Holdings sold 20,336 AstraZeneca shares in Q1 2026, an estimated $3.92M.
  • AstraZeneca made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1757 holding.
  • HSBC Holdings first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
  • HSBC Holdings's AstraZeneca position peaked at $494M in Q4 2021.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.